Financial Data and Key Metrics Changes - The company reported $74.9 million in revenue for Q4 2025, down from $120.8 million in Q4 2024, primarily due to the wind-down of migrant-related projects [15] - For the full year 2025, total revenue was $322.2 million compared to $616.6 million in 2024 [15] - Adjusted EBITDA loss for Q4 2025 was $11.3 million, compared to a profit of $1.1 million in Q4 2024 [16] - The adjusted gross margin for Q4 2025 was 32.5%, down from 33.5% in Q4 2024 [17] Business Line Data and Key Metrics Changes - Medical transportation services revenue increased to $50.2 million in Q4 2025 from $49.1 million in Q4 2024 [15] - Mobile Health revenue for Q4 2025 was $24.8 million, down from $71.8 million in Q4 2024, but non-migrant Mobile Health revenues increased by 47% [16] - SteadyMD generated $6.1 million in revenue for DocGo in Q4 2025, with full-year gross margins improving from approximately 30% to 37% [6][17] Market Data and Key Metrics Changes - The company saw strong growth in markets like New York, Texas, and Tennessee, contributing to revenue increases in medical transportation [16] - The number of assigned lives in the care gap closure program increased by 12% sequentially, from 1.3 million to over 1.45 million [10] Company Strategy and Development Direction - The company is focused on integrating SteadyMD into its mobile health offerings and aims to consolidate provider networks by the end of Q2 2026 [7] - The company plans to reduce cash outlay in 2026 as early markets mature and become self-sustaining, with a goal of achieving profitability in the second half of 2026 [11] - An efficiency innovation portfolio has been launched, expected to deliver $5-$6 million in savings in 2026 and $20-$24 million in 2027 [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong demand for services and top-line growth across volume metrics, despite challenges in achieving profitability [14] - The company anticipates a full-year adjusted EBITDA loss in the range of $5 million to $10 million for 2026, an improvement from previous guidance [24] - Management highlighted the importance of technology and automation in driving efficiency and reducing costs while maintaining high service levels [70] Other Important Information - The company has initiated a process to explore strategic alternatives aimed at maximizing shareholder value [13] - Cash and cash equivalents at year-end were $68.3 million, down from $95.2 million, primarily due to the acquisition of SteadyMD and delays in collecting migrant-related accounts receivable [21][22] Q&A Session Summary Question: Can you provide details on the strategic alternatives process? - The company has engaged an investment bank to run a formal process aimed at maximizing shareholder value, but cannot share further details at this time [26] Question: What are the components driving the increased 2026 guidance? - The increase in revenue guidance is primarily driven by improved volumes in the Medical Transportation segment and additional upside from SteadyMD [28] Question: Can you quantify the free cash flow pressures in 2026? - The company expects cash balance to be lower due to working capital requirements and ongoing operating losses, but anticipates collecting outstanding receivables [33][36] Question: What is the outlook for the payer business and pipeline? - The company continues to see momentum in the payer business, with an increase in covered lives and ongoing discussions with potential new payers [41][46] Question: How should we think about EBITDA cadence throughout the year? - Most of the adjusted EBITDA loss is expected in the first half of the year, with a transition to profitability in the second half as efficiency measures take effect [68]

Financial Data and Key Metrics Changes - For the full year 2025, the company reported record revenue of $981.3 million, representing a year-over-year growth of 4.5% and 3.8% on a currency neutral basis [4][5] - Adjusted EBITDA for the full year was $320.9 million, with a margin of 32.7%, both metrics exceeding the high end of guidance [5][25] - In Q4 2025, revenue reached $282.3 million, a year-over-year increase of 14.1% and 12.7% on a currency neutral basis [5][13] - Q4 adjusted EBITDA was $104.1 million, up 29.1% reported and 27.2% on a currency neutral basis, with a margin of 36.9% [5][25] Business Line Data and Key Metrics Changes - Creative revenue in Q4 was $149 million, up 4.6% year-on-year, driven by accelerated revenue from two large licensing deals, despite a 16% decline in agency revenue [20] - Editorial revenue for Q4 was $109.4 million, up 21.4% year-on-year, with growth across all four verticals: news, sport, entertainment, and archive [21][22] - Annual subscription revenue grew 1% year-over-year, with Premium Access, the largest subscription, up 4.1% in Q4 [18] Market Data and Key Metrics Changes - The Americas region saw a revenue increase of 20.8% in Q4 on a currency neutral basis, while EMEA was up 6.1% and APAC down 13% due to challenges in the agency business [17] - Active annual subscribers totaled 278,000 in Q4, down from 314,000 in the previous year, primarily due to the discontinuation of the free trial program [19] Company Strategy and Development Direction - The company aims to strengthen its recurring revenue base and expand long-term partnerships, as evidenced by securing significant multi-year licensing agreements [6][7] - Continued investment in machine learning capabilities to enhance content discovery and customer experience is a strategic focus [10] - The company is optimistic about future growth opportunities in video and custom AI training sets, indicating a proactive approach to evolving market demands [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's durable business model, highlighting strong customer relationships and a diversified revenue mix as key strengths [4][11] - The company anticipates a revenue range of $948 million to $988 million for 2026, reflecting a decline due to the timing of revenue recognition from large licensing agreements [32][34] - Management noted that the core business is expected to grow, excluding the impact of challenging year-on-year comparisons from the previous year [35] Other Important Information - The company reported a decrease in free cash flow to $7.7 million in Q4, attributed to higher cash interest expenses [27][28] - Total debt outstanding was $2.01 billion as of December 31, 2025, with a net leverage of 4.0x [29][30] Q&A Session Summary Question: Insights on licensing deals and their long-term applicability - Management highlighted the relevance of content in social media and large language models as key drivers for the licensing deals, indicating potential for more such agreements in the future [38][39] Question: Reasons for decline in active annual subscribers and retention rates - The decline in active annual subscribers was primarily due to the end of the free trial program, with expectations for retention rates to improve as the impact cycles through [40][42] Question: Clarification on 2026 revenue guidance and data licensing - Management clarified that the large deals recognized in Q4 are not purely data licensing deals, and while there is a pipeline for future deals, specifics are not included in the 2026 guidance [47][49]

Financial Data and Key Metrics Changes - The company generated sales of $515 million for 2025, a decrease of 6% compared to $547 million in the prior year, slightly below the target range of $520 million-$535 million [16] - Adjusted EBITDA for 2025 was $39.2 million, slightly better than the previous year's $39.1 million [17] - Gross profit margin increased to 29% in 2025, while operating expenses as a percentage of sales decreased to 27% [17] Business Line Data and Key Metrics Changes - U.S. crop business sales were similar to the previous year, with improvements in herbicide sales, particularly with the product Xelo [16][26] - Specialty sales improved by 10%, driven by a joint development agreement and growth in mosquito vector solutions [17] - International operations saw a 14% decline in sales due to elevated channel inventories in Mexico and drought conditions in Australia [16] Market Data and Key Metrics Changes - The agricultural sector has not yet recovered from a downturn that began in 2023, with commodity prices remaining below historically normal levels [12] - Farmers are making more last-minute crop decisions, influenced by geopolitical issues, with a forecasted slight decrease in cotton and corn acreage, while soybean acreage is expected to increase [12][13] Company Strategy and Development Direction - The company is focused on improving its capital structure to pay down expiring credit facilities while maintaining financial flexibility for growth [4][5] - Rationalization of the Los Angeles manufacturing facility is expected to save at least $4 million annually, with production moving to the Axis, Alabama site [6][8] - The company aims to launch five new products in North America in 2026 and register at least 25 new products by 2031, with expectations of generating an additional $100 million in annual revenue from new products [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about future performance, projecting adjusted EBITDA of $44 million-$48 million in 2026 on sales of $530 million-$550 million [14] - The company is confident in achieving a long-term EBITDA margin target of 15%, with a compound annual growth rate of 4%-6% expected [42][44] - Management acknowledged challenges in cash flow due to lower prepayments in Q4 but anticipates a favorable cash flow position in 2026 [33] Other Important Information - The company has remediated all material weaknesses identified during the 2024 audit, a significant achievement given the refinancing efforts [15] - Capital spending for 2025 was approximately $4 million, with expectations to increase in 2026 while remaining within the $5 million-$10 million range [19] Q&A Session Summary Question: What dragged on revenue and margin performance in Q4? - Management indicated that both international and domestic sales were affected, with lower metam sales and potato demand in the U.S. and drought conditions in Australia impacting international sales [25][26] Question: How do the L.A. closure and headquarters relocation fit into long-term transformation plans? - The rationalization of the L.A. facility and relocation of headquarters were not initially part of the transformation plan but became necessary as capacity utilization was analyzed [28][29] Question: Are there any cash proceeds associated with the closure of the Los Angeles facility? - There will be no immediate sale of the L.A. facility, which will continue to operate at a lower scale, but the headquarters relocation is expected to save $500,000 annually [30][32] Question: Is it possible to achieve free cash flow positive in 2026? - Management expressed confidence that adjusted EBITDA projections, less interest and capital expenditures, would lead to a favorable cash flow position in 2026 [33] Question: Can you provide more details on the $100 million expected from new products? - New products are primarily coming from insecticides and herbicides, with a mid-term definition extending to around 2030-2031 [37][40]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $28.2 million, down from $36.2 million in Q4 2024, impacted by user experience testing and traffic fluctuations [9] - Net income for Q4 2025 was $5.3 million (18.8% of revenue), compared to $6.9 million (19.1% of revenue) in the same period a year ago [9] - Full year revenue for fiscal 2025 was $134.8 million, up from $125.9 million in 2024, with non-advertising revenue increasing by over $21 million [10] - Adjusted EBITDA improved to $51.5 million (38.2% of revenue) in 2025, compared to $27 million (21.4% of revenue) in 2024 [11] Business Line Data and Key Metrics Changes - Advertising revenue represented 64% of total revenue in 2025, down from 74% in 2024, indicating a successful diversification strategy [10] - The company generated $13.1 million in cash from operating activities, enabling a $13 million repayment of its term loan in Q4 2025 [10] Market Data and Key Metrics Changes - The digital publishing landscape has been affected by recent search algorithm updates, leading to fluctuations in traffic patterns across the industry [5][6] - The company is focusing on diversifying revenue streams and reducing reliance on algorithm-driven traffic [6] Company Strategy and Development Direction - The company is evolving from a traditional publishing model to a brand, data, and IP company, leveraging first-party customer data to enhance its content-to-commerce strategy [13] - The acquisition of Lindy's Sports has contributed to a broader sports ecosystem and improved content offerings [14] - The company aims to maintain a disciplined approach to capital management, focusing on diversifying revenue and paying down debt [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to outperform the market despite traffic volatility, emphasizing a focus on controllable factors and cost structure [18][19] - The company anticipates continued positive cash flow generation in 2026 and is optimistic about its growth trajectory [12][15] Other Important Information - The company reduced its debt by $23.5 million in 2025 and increased its cash balance by $6 million to $10.3 million [12] - Management is prioritizing M&A opportunities to accelerate growth while maintaining flexibility in capital allocation [27][30] Q&A Session Summary Question: Traffic volatility in Q1 2026 - Management noted that traffic has been volatile due to algorithm updates, with some properties performing well while others face challenges, establishing a baseline for Q1 [18] Question: Margin expectations for 2026 - Management expects to continue reducing reliance on advertising revenue, aiming for below 50%, which may positively impact margins while balancing the growth of the ShopHQ business [21] Question: Acquisition cadence and capital allocation - Management anticipates continuing a cadence of one to two tuck-in media acquisitions per quarter while focusing on reducing debt and exploring growth opportunities [25] Question: Share repurchase and refinancing updates - Management has not yet completed share repurchases and is focused on debt reduction and value-accretive M&A, with refinancing discussions ongoing but no specific timeline provided [27][30]

Financial Data and Key Metrics Changes - The company generated sales of $515 million for 2025, a decrease of 6% compared to $547 million in the prior year, slightly below the target range of $520 million-$535 million [16] - Adjusted EBITDA for 2025 was $39.2 million, slightly better than the previous year's $39.1 million [17] - Gross profit margin increased to 29% in 2025, while operating expenses as a percentage of sales decreased to 27% [17] Business Line Data and Key Metrics Changes - U.S. crop business sales were similar to the previous year, with improvements in herbicide sales, particularly with the Xelo product [16][26] - Specialty sales improved by 10%, driven by a joint development agreement and growth in mosquito vector solutions [17] Market Data and Key Metrics Changes - International sales were down 14% due to elevated channel inventories in Mexico and a persistent drought in Australia [16] - The agricultural economy has not yet recovered from a downturn that began in 2023, with farmers making more last-minute crop decisions [12] Company Strategy and Development Direction - The company is focused on rationalizing its manufacturing footprint, including the closure of the Los Angeles facility, which is expected to save at least $4 million annually [6][8] - A move to a smaller, more cost-effective headquarters in Irvine, California, is expected to save approximately $0.5 million annually [8] - The company aims to launch five new products in North America in 2026 and register at least 25 new products by 2031, with an estimated additional $100 million in annual revenue from new products [10][11] Management's Comments on Operating Environment and Future Outlook - Management noted that the worst of the industry destocking appears to be in the past, but distributors have not shown an inclination to restock inventories [12] - The company expects adjusted EBITDA of $44 million-$48 million in 2026 on sales of $530 million-$550 million, indicating optimism for improved performance [14] Other Important Information - The company has remediated all material weaknesses identified during the 2024 audit, a significant achievement [15] - The company plans to further decrease net working capital and improve operational efficiency through experienced supply chain leaders and modern management techniques [18] Q&A Session Summary Question: What dragged on revenue and margin performance? - Management indicated that both international and domestic sales were affected, with lower Metam sales and demand for potato products in the U.S. contributing to the shortfall [25][26] Question: How do the L.A. closure and headquarters relocation fit into long-term plans? - The rationalization of the L.A. facility and the move of headquarters were not part of the initial transformation plan but became necessary as capacity utilization was analyzed [28][29] Question: Are there any cash proceeds associated with the facility closures? - There will be no immediate sale of the L.A. facility, which will continue to operate at a lower scale, and the headquarters move is expected to save on lease costs [30][32] Question: Is it possible to achieve free cash flow positive in 2026? - Management expressed confidence that adjusted EBITDA projections, less interest and capital expenditures, should lead to a favorable cash flow position in 2026 [33] Question: Can you provide details on the $100 million from new products? - New products are primarily coming from insecticides and herbicides, with a mid-term definition extending to around 2030-2031 [37][40]

Financial Data and Key Metrics Changes - For the full year 2025, the company reported record revenue of $981.3 million, representing a year-over-year growth of 4.5% and 3.8% on a currency neutral basis [4][5] - Adjusted EBITDA for the full year was $320.9 million, with a margin of 32.7%, both metrics exceeding the high end of guidance [5][25] - In Q4, revenue reached $282.3 million, a year-over-year increase of 14.1% and 12.7% on a currency neutral basis, with adjusted EBITDA rising to $104.1 million, up 29.1% reported and 27.2% on a currency neutral basis [5][13] Business Line Data and Key Metrics Changes - Creative revenue in Q4 was $149 million, up 4.6% year-on-year, while editorial revenue was $109.4 million, up 21.4% year-on-year [20][21] - Annual subscription revenue grew 1% year-over-year, with Premium Access, the largest subscription, up 4.1% in Q4 [18] - Custom content grew by more than 20%, and Unsplash+ subscribers increased by over 30% to more than 50,000 [8] Market Data and Key Metrics Changes - The Americas region saw a revenue increase of 20.8% in Q4 on a currency neutral basis, while EMEA was up 6.1% and APAC was down 13% [17] - The agency business faced challenges, while corporate and media segments returned to growth in Q4, with corporate growth exceeding 25% [16][17] Company Strategy and Development Direction - The company aims to strengthen its recurring revenue base and expand long-term partnerships, focusing on high-quality content and customer relationships [4][7] - New multi-year licensing agreements were secured, including partnerships with a major social platform and a large AI company, which are expected to enhance revenue streams [6][15] - The company is investing in machine learning capabilities to improve content discovery, reinforcing its competitive advantage [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to perform consistently despite broader market variability, citing a strong pipeline of long-term deals and customer demand for high-quality content [11][12] - The company anticipates revenue for 2026 to be between $948 million and $988 million, reflecting a decline due to the timing of revenue recognition from large licensing agreements [32][34] Other Important Information - The company ended 2025 with $90.2 million in cash, down from the previous year, primarily due to merger-related expenses [28] - Total debt outstanding was $2.01 billion, with a net leverage of 4.0x at the end of Q4 [29][30] Q&A Session Summary Question: Insights on licensing deals and their long-term applicability - Management highlighted the relevance of content in social media and large language models as key drivers for the licensing deals, indicating potential for more such agreements in the future [38][39] Question: Reasons for decline in active annual subscribers and retention rates - The decline in active annual subscribers was attributed to the cessation of the free trial program, with expectations for retention rates to improve as the impact of this change cycles through [40][42] Question: Mix of data licensing for training purposes relative to display licensing - Management clarified that the large deals discussed do not pertain to pure data licensing and that specific revenue projections for 2026 have not been quantified [45][47]

Financial Data and Key Metrics Changes - Total product sales in Q4 2025 were $12.8 million, down from $29.6 million in the prior year, primarily due to the timing of channel inventory related to ROLVEDON [17] - ROLVEDON net sales were minimal at $0.4 million in Q4, down from $15.4 million in the prior year, but underlying demand remains stable [18] - Gross margin improved to 75% compared to 61% in the prior year, driven by a higher mix of Indocin sales and the absence of prior-year inventory write-downs [18][21] - Full year 2025 total product sales were $117.1 million, exceeding the high end of the updated guidance range [20] Business Line Data and Key Metrics Changes - SYMPAZAN sales increased to $3.1 million in Q4 from $2.5 million in the prior year, reflecting higher volume and a favorable payer mix [18] - Indocin sales in Q4 were flat year-over-year at $5.5 million, with higher net pricing offsetting expected volume pressure from generic competition [18] Market Data and Key Metrics Changes - ROLVEDON continues to perform well, particularly in the community oncology clinic segment, maintaining strong market share [12] - The company expects to see new accounts purchasing ROLVEDON each quarter, indicating ongoing opportunities for expansion [12] Company Strategy and Development Direction - The company aims to leverage the commercial organization built around ROLVEDON to bring other products to market, focusing on oncology [7][9] - Assertio's strategy has shifted from acquiring on-market specialty products to being more selective in pursuing assets that can drive sustainable returns [8] - The core strategy will focus on maximizing ROLVEDON sales growth and implementing a lifecycle management strategy [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the revenue opportunity for ROLVEDON, with expectations for continued demand growth and an acceleration in sales starting in Q2 2026 [6][24] - The company is entering a new phase from a position of strength, with a solid balance sheet and a core asset with significant growth potential [10][26] Other Important Information - The company anticipates revenue guidance for fiscal 2026 in the range of $110 million to $125 million, with adjusted EBITDA guidance between $28 million and $40 million [22][24] - The expected growth in ROLVEDON is anticipated to offset declines in legacy tail assets [24] Q&A Session Summary Question: What types of assets is the company looking for in the oncology space? - The company is focused on on-market, late-stage development therapeutics, primarily in oncology [29] Question: Will there be any incremental investments required for new products? - The company believes that only a small incremental investment will be needed to support new product acquisitions [30] Question: What gives the company confidence in ROLVEDON's growth guidance for 2026? - The company noted a 32% year-over-year demand growth for ROLVEDON in 2025, indicating strong underlying demand [35] Question: Is there a plan to expand beyond the community oncology setting? - The current plan is to continue focusing on the community oncology space, where the company has a leading market share, while remaining open to other opportunities [40] Question: Will channel inventory build in 2026 for the relabeled ROLVEDON? - The company does not expect channel inventory to build, anticipating that quarterly demand will align with quarterly shipments [47] Question: What is the long-term potential for ROLVEDON? - The company is optimistic that ROLVEDON could exceed $100 million in annual sales, with potential targets ranging from $100 million to $130 million [62]

Financial Data and Key Metrics Changes - Semtech achieved record net sales of $1.05 billion for fiscal year 2026, reflecting a 15% year-over-year growth [5] - Q4 net sales were $274.4 million, up 3% sequentially and 9% year-over-year [5] - Adjusted diluted earnings per share for Q4 were $0.44, a 10% increase year-over-year, while for the fiscal year, it was $1.71, representing a 94% growth [6][30] - Adjusted gross margin was 51.6%, with total semiconductor products gross margin at 61.7%, up 40 basis points sequentially and 350 basis points year-over-year [28] Business Line Data and Key Metrics Changes - Infrastructure net sales for Q4 were $86.3 million, up 11% sequentially and 25% year-over-year, with fiscal year sales at $310 million, a 27% increase [8] - Data center net sales reached a record $63 million in Q4, up 12% sequentially and 26% year-over-year, with annual growth of 58% to $223 million [9] - High-end consumer net sales for Q4 were $36.6 million, down 13% sequentially but up 3% year-over-year, with fiscal year sales at $155.1 million, a 5% increase [17] - Industrial net sales for Q4 were $151 million, up 3% sequentially and year-over-year, with full-year revenue at $584 million, a 13% growth [19] Market Data and Key Metrics Changes - Demand for 800G PIA solutions remains strong, with expectations for continued growth throughout 2026 [10] - LoRa revenues for Q4 were $39.6 million, up 7% year-over-year, with full-year revenues at $156 million, representing a 34% growth [19] - The IoT systems and connectivity business recorded Q4 net sales of $89.9 million, up 2% sequentially but down 3% year-over-year, with fiscal year revenues at $354 million, a 9% increase [23] Company Strategy and Development Direction - The acquisition of HieFo Corporation is seen as a strategic move to enhance capabilities in high-efficiency Indium Phosphide-based optoelectronic devices, critical for optical transceivers [6][7] - The company aims to optimize its product portfolio and expand domestic capacity, particularly in the data center segment [7][8] - Semtech is focused on accelerating business growth, intensifying R&D investment, and transforming its culture while optimizing its portfolio [25][26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for multi-year growth opportunities, particularly in the AI data center build-out [25] - The outlook for fiscal year 2027 includes expected net sales of $283 million, up 13% year-over-year, with significant contributions from data center growth and high-end consumer products [33] - Management anticipates data center year-over-year revenue growth to exceed 50% in fiscal year 2027, driven by new product ramps [17][88] Other Important Information - The company is making progress on the divestiture of its cellular module business, with increased interest from potential acquirers [8][77] - Semtech's cash and cash equivalents balance at the end of Q4 was $195.2 million, with a net leverage ratio of 1.3, down from 1.5 sequentially [32] Q&A Session Summary Question: Can you expand on the initial applications targeted with the HieFo acquisition? - The initial product in production is a gain chip for tunable lasers, with expected contributions to revenue in the high teens for 2027 [40] Question: How should we think about the CapEx line for capacity expansions? - CapEx intensity is moderate, and the company plans to support capacity expansion with free cash flow [44] Question: Can you provide insights on the potential size of the CopperEdge business? - The company is preparing to start shipping to cable manufacturers, but it is still too early to provide specific revenue estimates [50] Question: What is the long-term growth rate expected for LoRa? - The long-term growth rate for LoRa is expected to be approximately 20%, with quarterly sales ranging from $35 million to $45 million [23][56] Question: How will the Indium Phosphide laser acquisition be marketed? - The company plans to provide integrated solutions by co-developing products and offering reference designs to accelerate time to market for customers [62]

Financial Data and Key Metrics Changes - For the full year 2025, net sales increased by 16% to $58.6 million, primarily driven by a 34% growth in the OEM channel [5][18] - Fourth quarter net sales grew by 6.9% to $13.1 million, with OEM revenue increasing approximately 30% year-over-year [17] - Gross profit for the fourth quarter was $2.4 million, with a gross margin of 18.2%, compared to a gross profit of $2.5 million and a gross margin of 20.8% in the previous year [17][18] - Operating expenses increased by 29.9% to $12.6 million, which included one-time expenses due to debt restructuring [18] - Net loss for the fourth quarter was $45 million, compared to a net loss of $9.8 million in the previous year [18] - Adjusted EBITDA improved to negative $11.4 million from negative $18.5 million for the full year [18] Business Line Data and Key Metrics Changes - The OEM channel was a significant driver of growth, with revenue from this segment growing 34% year-over-year [5][18] - Direct-to-Consumer (DTC) revenue declined to $4.7 million from $5.7 million, reflecting ongoing market headwinds and a shift in corporate focus [17] Market Data and Key Metrics Changes - The heavy-duty trucking market is seen as a compelling long-term opportunity, with fleets increasingly focused on reducing fuel consumption and improving operational efficiency [10][11] - The RV market experienced weaker demand in January, but signs of recovery were noted in February and early March [25][26] Company Strategy and Development Direction - The company is focused on strengthening its financial foundation, expanding its commercial footprint, and validating its technology across multiple industries [4] - A strategic realignment of the cost structure was implemented, including a 20% reduction in cash compensation for executive leadership and targeted workforce adjustments [7][8] - The company aims to achieve positive adjusted EBITDA as it approaches an annual revenue run rate of approximately $70 million [9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged continued pressure from the broader economic environment, particularly in the RV market, but noted signs of stabilization [19] - The company expects first quarter revenue to be approximately $9.5 million and an adjusted EBITDA loss of $4.6 million, with improved operating leverage anticipated as the year progresses [20][21] Other Important Information - The company has advanced its intellectual property portfolio, now including almost 90 issued or pending patents [6] - The Battle Born DualFlow Power Pack received external recognition with the SEAL Sustainable Product Award, highlighting its environmental benefits [13] Q&A Session Summary Question: RV OEM market outlook - Management noted weaker demand in January but observed recovery in February and early March, with expectations for expanded energy storage capacity among existing OEMs [25][26] Question: Heavy-duty trucking market expectations - Management anticipates a pickup in capital expenditures in the second half of the year, driven by new engine releases and increased fleet commitments [28] Question: DTC business strategy - The company has seen a steady decline in DTC revenue and is focusing on growth in OEM partnerships instead [31] Question: Customer feedback on expanded product lines - Management reported positive feedback on full systems integration, which has led to increased revenue across segments [36] Question: Exposure to lithium carbonate price volatility - While the industry is susceptible to raw material price increases, the company has not yet experienced significant impacts [38] Question: Cash burn outlook for 2026 - Management is focused on reducing spending and improving cash flow, with expectations for better performance in adjacent markets [42]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $28.2 million, down from $36.2 million in Q4 2024, impacted by user experience testing and traffic fluctuations [9] - Net income for Q4 2025 was $5.3 million (18.8% of revenue), compared to $6.9 million (19.1% of revenue) in the same period a year ago [9] - Full year revenue for fiscal 2025 was $134.8 million, up from $125.9 million in 2024, with non-advertising revenue increasing by over $21 million [10] - Adjusted EBITDA improved to $51.5 million (38.2% of revenue) in 2025, compared to $27 million (21.4% of revenue) in 2024 [11] Business Line Data and Key Metrics Changes - Advertising revenue represented 64% of total revenue in 2025, down from 74% in 2024, indicating a shift towards non-advertising revenue streams [10] - The company has focused on diversifying revenue sources, which has positively impacted profitability and margin retention [11] Market Data and Key Metrics Changes - The digital publishing landscape has been affected by recent search algorithm updates, leading to fluctuations in traffic patterns across the industry [5] - The company views these changes as a catalyst for innovation and growth, adapting strategies to optimize content and diversify revenue streams [6] Company Strategy and Development Direction - The company is transitioning from a traditional publishing model to a brand, data, and IP company, leveraging first-party customer data to create a closed-loop ecosystem [13] - Strategic investments in technology and product development are aimed at capitalizing on emerging opportunities and driving sustainable growth [7] - The company plans to continue its focus on diversifying revenue, reducing debt, and maintaining a disciplined approach to capital management, including M&A activities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to industry changes and generate positive cash flow in 2026 despite ongoing traffic volatility [12] - The company anticipates a baseline level of performance in Q1 2026, with a focus on controlling factors within its operations [18][19] Other Important Information - The company reduced its debt by $23.5 million in 2025 and increased its cash balance by nearly $6 million to $10.3 million [5][12] - The company is exploring opportunities for tuck-in acquisitions to accelerate growth while maintaining a focus on reducing reliance on advertising revenue [25] Q&A Session Summary Question: What has been observed in Q1 2026 regarding traffic volatility? - Management noted that traffic has been volatile due to algorithm updates, with some properties performing well while others experience fluctuations [18] Question: How are margins expected to trend in 2026 with investments in non-advertising revenue? - Management indicated that they aim to reduce reliance on advertising revenue below 50%, which may positively impact margins, while also considering the different margin profile of the ShopHQ business [21] Question: Will the company continue with acquisitions in 2026? - Management confirmed the intention to maintain a cadence of 1-2 tuck-in acquisitions per quarter while focusing on accelerating company growth [25] Question: What is the status of the share repurchase program and debt refinancing? - Management stated that share repurchases are on hold until after debt refinancing, which is being approached with discipline to secure the right deal [27][30]